CVS vs CI
CVS and CI side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CVSCVS HEALTH Corp | CIThe Cigna Group |
|---|---|---|
| Market cap | $102.49B | $81.02B |
| P/E (TTM) | 9.3 | 12.7 |
| P/B | 1.27 | 1.90 |
| P/S | 0.3x | 0.3x |
| Dividend yield | 3.31% | 1.99% |
| Revenue | $420.61B(TTM) | $282.38B(TTM) |
| Revenue growth (YoY) | 7.8% | 11.2% |
| Net income | $11.04B(TTM) | $6.42B(TTM) |
| Earnings growth (YoY) | -61.7% | 73.5% |
| EPS, diluted | $8.61(TTM) | $24.18(TTM) |
| EBIT margin | 1.2% | 3.3% |
| ROE | 2.2% | 14.0% |
| ROIC | 2.9% | 9.5% |
| Piotroski F | 6/9 | — |
| 1y total return | +6.8% | +18.1% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: CVS vs CI
| Metric | CVS | CI |
|---|---|---|
| End value | $11.7K | $26.9K |
| Total return | +16.7% | +169.4% |
| CAGR | +1.5% | +10.1% |
| Volatility | 29.1% | 30.6% |
| Sharpe | 0.05 | 0.33 |
| Sortino | 0.07 | 0.47 |
| Max drawdown | -56.8% | -42.5% |
Based on 2600 common trading days, 2016-07-05 → 2026-11-04 · risk-free 4.21% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)